Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04740411
Other study ID # 844589
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2021
Est. completion date March 1, 2022

Study information

Verified date May 2021
Source University of Pennsylvania
Contact Akash Wasil, MA
Phone 631-766-9466
Email wasil@sas.upenn.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We are evaluating the effects of an online single-session mental health intervention (the Common Elements Toolbox; COMET). To evaluate COMET, we are conducting a randomized controlled trial with college students attending American universities. Students will be randomized to the COMET condition or to a wait-list control condition.


Recruitment information / eligibility

Status Recruiting
Enrollment 850
Est. completion date March 1, 2022
Est. primary completion date March 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - At least 18 years old and a student at a participating university. Access to the internet. Exclusion Criteria: - Cannot have participated in a previous version of COMET.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
The Common Elements Toolbox (COMET)
COMET is an online unguided self-help intervention that lasts approximately 60-80 minutes.

Locations

Country Name City State
United States University of Pennsylvania Philadelphia Pennsylvania

Sponsors (4)

Lead Sponsor Collaborator
University of Pennsylvania Indiana University, Ohio State University, University of Missouri, St. Louis

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the Patient Health Questionnaire-9 (PHQ-9) Depression questionnaire. Scores range from 0 to 27. Lower scores indicate less depression. Up to 8 weeks post-intervention
Primary Change in the Generalized Anxiety Disorder Screener-7 (GAD-7) Anxiety questionnaire. Total scores range from 0-21. Lower scores indicate less anxiety. Up to 8 weeks post-intervention
Primary Change in the Short Warwick-Edinburgh Mental Well-being Scale Subjective Well-being questionnaire. Total scores range from 7 to 35. Higher values indicate higher well-being scores. Up to 8 weeks post-intervention
Primary Change in items from the PERMA Profiler (positive emotion and negative emotion subscales). Well-being questionnaire with questions related to positive emotion, engagement, relationships, meaning, accomplishment, negative emotion, and health. Scores on each item range from 0 to 5. Lower scores indicate less well-being. We are using a shortened version of this questionnaire with 12 items. We have also modified the items to ask participants about their experiences over the past 48 hours. We predict that our intervention will produce changes in the positive emotion and negative emotion subscales. Each subscale consists of 3 items. Up to 8 weeks post-intervention
Secondary Ratings on the Acceptability of Intervention Measure (AIM) Questionnaire measuring the acceptability of an intervention. Acceptability refers to the perception that a given treatment is agreeable or satisfactory. The total score ranges from 4 to 20. Higher scores indicate higher acceptability ratings. Immediately after the intervention
Secondary Ability to Cope with COVID-19 2 questions related to their ability to cope with stressors over the past two weeks relating to the COVID-19 pandemic. Participants answered these questions on a 7-point Likert Scale, from "strongly disagree" to "strongly agree". Specifically, we asked participants: a) if they have been able to handle lifestyle changes due to the coronavirus and b) if the pandemic has had an extremely negative impact on their life. Up to 8 weeks post-intervention
Secondary Change in Secondary Control We administered three items to assess secondary control, derived from the Secondary Control Scale for Children (Weisz et al., 2010). The items are scored on a 4-point Likert scale, ranging from 0 ("Very false") to 3 ("Very true"). Scores on each item range from 0-4, with higher scores indicating more secondary control. Up to 8 weeks post-intervention
Secondary Change in the Positive and Negative Affect Schedule Questionnaire measuring positive affect and negative affect. Scores on the positive affect subscale range from 10-50, with higher scores representing higher levels of positive affect. Scores on the negative affect subscale range from 10-50, with lower scores representing lower levels of negative affect. Up to 8 weeks post-intervention
Secondary Perceived Utility Ratings Participants were asked to rate three items relating to the perceived utility of each module. Specifically, we asked participants: How helpful the module was How engaging the module was How much they will continue applying content from the module. Higher scores indicate greater perceived utility. Immediately after the intervention
Secondary Change in the Perceived Stress Scale-4 Questionnaire measuring perceived stress. Scores range from 0-16, with higher scores indicating greater stress. Up to 8 weeks post-intervention
Secondary Change in the Gratitude Adjective Checklist Gratitude measure. Three items rated on a 1-5 scale with total scores ranging from 3-15. Higher scores indicate higher levels of gratitude. Up to 8 weeks post-intervention
Secondary Change in the Self-kindness subscale of the Self-Compassion Scale Self-compassion measure. We are using the 5-item self-kindness subscale. Participants will provide values ranging from 1 to 5. These values will be summed to create a total score on this scale ranging from 5 to 25, with higher scores representing higher levels of self-compassion. Up to 8 weeks post-intervention
Secondary Change in Cognitive Restructuring We administered three items to assess cognitive restructuring, derived from the cognitive reappraisal subscale of the Emotion Regulation Questionnaire. Scores range from 3-21, with higher scores representing a higher amount of cognitive restructuring. Up to 8 weeks post-intervention
Secondary Change in items from the Behavioral Activation for Depression Scale Behavioral Activation Measure. We selected 3 items from the BADS to use to assess changes in behavioral activation. The scores for these three items are summed to give a total score from 0-18. Higher scores represent higher levels of behavioral activation. Up to 8 weeks post-intervention
Secondary Beck Hopelessness Scale Hopelessness Questionnaire. Total score ranges from 0 to 4. Higher scores indicate less hope (more hopelessness). Up to 8 weeks post-intervention
Secondary Change in module-specific skills We are administering 4 items designed to detect cognitive or behavioral changes that relate to each intervention module.
Cognitive restructuring: "Over the past two weeks, I have been able to manage negative thoughts."
Behavior activation: "Over the past two weeks, I have intentionally spent time performing hobbies and activities that make me happy."
Gratitude: "Over the past two weeks, I have been able to focus my attention toward noticing and appreciating good things."
Self-compassion: "Over the past two weeks, I have been able to treat myself with empathy and compassion."
For each item, participants respond using a 7-point scale ranging from strongly disagree to strongly agree. Higher scores indicate favorable cognitions and behaviors related to each construct.
Up to 8 weeks post-intervention
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A